Kaken Pharmaceutical (4521.TSE) Q2 2025 Earnings

May 12Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-139
24
188
351

Details

Expected EPS
N/A
Actual EPS
-139
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Kaken Pharmaceutical⁩ (⁦4521.TSE⁩) has reported earnings of ⁦-139⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts